In addition to the PD-1/PD-L1 immune checkpoint, curcumin could downregulate the tumor immunotherapeutic molecule CTLA-4 at both protein and mRNA levels (Zhao et al., 2012). This evidence concerns the gene CD274 and neoplasm.